Global /China /Healthcare /Drug Manufacturers - General /605199

Hainan Huluwa Pharmaceutical Group Co., Ltd.

605199

• SSE: 605199 • Delayed

6.79CNY -0.3%

1.00 USD

As of 4 July 2026, Hainan Huluwa Pharmaceutical Group Co., Ltd. has a market cap of $400.24M USD, ranking #16653 globally and #5224 in China. It ranks #1507 in the Healthcare sector, and #550 in the Drug Manufacturers - General industry.

Global Rank

16653

1d: -12

1w: -

1m: -

Country Rank

5224

1d: -5

1w: -

1m: -

Sector Rank

1507

1d: -2

1w: -

1m: -

Industry Rank

550

1d: -1

1w: -

1m: -

Key Stats

Market Cap

$400.24MUSD

2.72B CNY

Enterprise Value

$568.15MUSD

3.86B CNY

Revenue (TTM)

$132.71MUSD

900.84M CNY

EBITDA (TTM)

-$9.2MUSD

-62.45M CNY

Net Income (TTM)

-$42.34MUSD

-287.37M CNY

EBITDA Margin

-6.9%

Profit Margin

-32%

PS Ratio

3.0

PB Ratio

5.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jinping Liu open_in_new

Employees

2,103

Founded

2005

Website

huluwayaoye.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	1.5%	5.9%	-0.3%	-25%	-11%	-48%	-60%	-76%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	605199 海南葫芦娃药业集团股份有限公司 Class A ISIN: CNE100004223 Shares Out.: Shares Outstanding: 400.109M¹ Shares Float: 93.341M² TV: TradingView: SSE: 605199 SA: Stock Analysis: SHA: 605199 YF: Yahoo Finance: 605199.SS GF: Google Finance: SHA: 605199 BA: Barron's: 605199 MS: Morningstar: XSHG: 605199	6.79 CNY	TV: TradingView: SSE: 605199 SA: Stock Analysis: SHA: 605199 YF: Yahoo Finance: 605199.SS GF: Google Finance: SHA: 605199 BA: Barron's: 605199 MS: Morningstar: XSHG: 605199

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hainan Huluwa Pharmaceutical Group Co., Ltd.

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.76B 364.89B CNY 13K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.55B 336.36B CNY 12K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 7K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.78B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.48B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 190K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 137K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 90K%	97.4	United States
Roche Holding AG SIX: RO	$318.9B 256.25B CHF 80K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.77B 215.59B GBP 72K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 68K%	15.1	United States

chevron_leftBack